[go: up one dir, main page]

CN113558825B - An interventional valve stent and valve - Google Patents

An interventional valve stent and valve Download PDF

Info

Publication number
CN113558825B
CN113558825B CN202110842126.3A CN202110842126A CN113558825B CN 113558825 B CN113558825 B CN 113558825B CN 202110842126 A CN202110842126 A CN 202110842126A CN 113558825 B CN113558825 B CN 113558825B
Authority
CN
China
Prior art keywords
valve
support
stent
section
skirt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110842126.3A
Other languages
Chinese (zh)
Other versions
CN113558825A (en
Inventor
王建安
刘先宝
扶志彬
于大伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Xinchang Medical Instrument Co ltd
Zhejiang University ZJU
Original Assignee
Hangzhou Xinchang Medical Instrument Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Xinchang Medical Instrument Co ltd filed Critical Hangzhou Xinchang Medical Instrument Co ltd
Priority to CN202110842126.3A priority Critical patent/CN113558825B/en
Publication of CN113558825A publication Critical patent/CN113558825A/en
Application granted granted Critical
Publication of CN113558825B publication Critical patent/CN113558825B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2463Implants forming part of the valve leaflets

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

The application relates to an interventional valve support and a valve, the valve support comprises a body part, the body part is provided with a plurality of flap openings, the flap openings are provided with side walls, at least one first supporting part is arranged in at least part of the flap openings, and the first supporting part is connected with the side walls. According to the application, the first supporting part is arranged in the orifice of the valve support, so that the supporting performance of the valve support can be improved, and after the valve is placed in a patient, the supporting force of the valve support and a diseased valve of the patient can be improved, so that the risk that the valve falls off from the diseased valve is reduced, the position accuracy of the valve is improved, the working performance of the valve is improved, and the safety of the patient is ensured.

Description

Interventional valve support and valve
Technical Field
The application relates to the technical field of medical equipment, in particular to an interventional valve support and a valve.
Background
Traditional heart valve replacement surgery is an open, high-invasive procedure, is traumatic to the procedure and requires extracorporeal circulation, is at high risk, and is prone to adverse effects such as massive hemorrhage, infection, arrhythmia, etc. during the procedure, resulting in patients taking even several months to recover. Although the aortic valve replacement through the apex of the heart approach has small operation wound, the heart of the patient is still wounded, and long-time pain is brought in the recovery process. In recent years, researchers have focused on performing prosthetic heart valve replacement without opening the chest cavity or placing the patient in extracorporeal circulation in an effort to minimize trauma, the biological valve being capable of being deployed across the patient's own valve, thereby avoiding excision of the patient's diseased valve.
Because the biological valve is supported on the self valve of the patient, the risk of falling off exists when the support force of the valve support in the biological valve is insufficient or the support force of the valve support in the biological valve is not fixed, and the life safety of the patient is affected.
Disclosure of Invention
The application provides an interventional valve support and a valve, wherein the valve support has good supporting and fixing performances and can prevent the valve from falling off.
The first aspect provides an interventional valve stent comprising a body portion provided with a plurality of petals having side walls;
At least one first supporting part is arranged in at least part of the flap openings, and the first supporting part is connected with the side wall.
In one possible design, the first support divides the orifice into at least one quadrilateral configuration.
In one possible design, the first support comprises at least a first section and a second section that are bent relatively;
Along the first direction, the first section is connected with one end of the second section, and the other ends of the first section and the second section are respectively connected with the corresponding side walls.
In one possible design, the first section, the second section, and the sidewall are the same length such that the first section, the second section, and the sidewall enclose a diamond or square.
In one possible design, at least two first supporting portions are disposed in the flap opening along the second direction, and a preset distance is provided between adjacent first supporting portions.
In one possible design, at least part of the first support can be convex towards the outside of the orifice, or at least part of the first support can be concave towards the outside of the orifice.
In one possible design, the orifice is hexagonal in shape.
In one possible design, the material of the valve stent comprises cobalt-based alloy, stainless steel, or nickel titanium.
In a second aspect, the application provides a valve comprising:
a valve stent, which is the interventional valve stent;
And the valve leaflet is mounted on the valve bracket.
In one possible design, the valve is a balloon expandable valve.
According to the application, the first supporting part is arranged in the orifice of the valve support, so that the supporting performance of the valve support can be improved, the supporting force of the valve support and a lesion valve of a patient can be improved after the valve is placed in the patient, and the anchoring capacity of the valve in an interventional operation is improved, so that the risk that the valve falls off from the lesion valve is reduced, the position accuracy of the valve is improved, the working performance of the valve is improved, and the safety of the patient is ensured.
It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the application as claimed.
Drawings
FIG. 1 is a schematic view of a valve according to a first embodiment of the present application;
FIG. 2 is a schematic view of a valve according to another embodiment of the present application;
FIG. 3 is a schematic view of a portion of the valve stent of FIGS. 1 and 2 in a first embodiment;
FIG. 4 is a schematic view of a portion of the valve stent of FIGS. 1 and 2 in a second embodiment;
FIG. 5 is a schematic view of a portion of the valve stent of FIGS. 1 and 2 in a third embodiment;
FIG. 6 is a schematic view of a portion of the valve stent of FIGS. 1 and 2 in a fourth embodiment;
FIG. 7 is a schematic view of a portion of the valve stent of FIGS. 1 and 2 in a fifth embodiment;
FIG. 8 is a schematic view of a portion of the valve stent of FIGS. 1 and 2 in a sixth embodiment;
FIG. 9 is a schematic view of a portion of the valve stent of FIGS. 1 and 2 in a seventh embodiment;
FIG. 10 is a schematic view of a portion of the valve stent of FIGS. 1 and 2 in an eighth embodiment;
FIG. 11 is a schematic view of a portion of the valve stent of FIG. 1;
FIG. 12 is a schematic view of the valve stent of FIG. 2;
FIG. 13 is a schematic view of a portion of the valve stent of FIGS. 1 and 2 in a ninth embodiment;
Fig. 14 is a top view of the leaflet of fig. 1 and 2.
Reference numerals:
1-a valve stent;
11-a body portion;
111-a first mounting port;
112-a second mounting port;
12-flap opening;
121-sidewalls;
13-a first support;
131-first stage;
132-a second section;
14-a second support;
2-leaflet;
21-a first leaflet;
22-a second leaflet;
23-third leaflet;
3-skirt edge;
X-a first direction;
Y-second direction.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the application and together with the description, serve to explain the principles of the application.
Detailed Description
For a better understanding of the technical solution of the present application, the following detailed description of the embodiments of the present application refers to the accompanying drawings.
It should be understood that the described embodiments are merely some, but not all, embodiments of the application. All other embodiments, which can be made by those skilled in the art based on the embodiments of the application without making any inventive effort, are intended to be within the scope of the application.
The terminology used in the embodiments of the application is for the purpose of describing particular embodiments only and is not intended to be limiting of the application. As used in this application and the appended claims, the singular forms "a," "an," and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise.
It should be understood that the term "and/or" as used herein is merely an association relationship describing the associated object, and means that there may be three relationships, e.g., a and/or B, and that there may be three cases where a exists alone, while a and B exist together, and B exists alone. In addition, the character "/" herein generally indicates that the front and rear associated objects are an "or" relationship.
It should be noted that, the terms "upper", "lower", "left", "right", and the like in the embodiments of the present application are described in terms of the angles shown in the drawings, and should not be construed as limiting the embodiments of the present application. In the context of this document, it will also be understood that when an element is referred to as being "on" or "under" another element, it can be directly on the other element or be indirectly on the other element through intervening elements.
The embodiment of the application provides a valve and a valve support 1 thereof, as shown in fig. 1 and 2, the valve comprises the valve support 1, valve leaflets 2 and a skirt 3, wherein the valve leaflets 2 and the skirt 3 are arranged on the valve support 1, the valve leaflets 2 are positioned in a space formed by the valve support 1, the valve support 1 can be in a grid structure, and the skirt can seal grids of the valve support 1 through different designs and sewing, so that blood can be prevented from flowing back from a primary valve gap when blood in a heart flows back. Wherein, the material of the skirt 3 can be PET, PTFE or biological tissue material.
The expansion mode of the valve can comprise a balloon expansion mode and a self-expansion mode, wherein the balloon expansion mode is used for placing a balloon in the transcatheter aortic valve, the valve is expanded by pressurization after being input into a body through a conveying system, and then the valve is driven to expand and anchor at a lesion position, the self-expansion mode is used for realizing expansion through the inherent characteristics of the transcatheter aortic valve stent material, when the valve is placed into a human body, the transcatheter aortic valve is radially compressed and placed in a conveying system catheter, and after the valve is placed into the human body, the catheter is retracted, so that the valve can be self-expanded to the original size without restraint, and then the valve is anchored at the lesion position. Thus, the valve that expands in the manner of a balloon is a balloon-expanded valve and the valve that expands in the manner of a self-expanding valve is a self-expanding valve.
After the valve is put into a human body, taking the view angles shown in fig. 1 and 2 as an example, blood flows from top to bottom, and under the pressure of the blood, the valve leaves 2 are opened to open the blood channel of the valve, at the moment, the valve is in an open state, when the pressure of the blood is eliminated, the valve leaves 2 can be deformed and closed to block the blood channel of the valve, so that the blood is prevented from flowing backwards, and at the moment, the valve is in a closed state. Meanwhile, after the valve is placed into a human body, the valve can be usually supported at a lesion valve of the human body, so that the lesion valve is replaced to work. Therefore, it is necessary to ensure the position of the valve after the valve is placed in the human body, that is, the valve needs to be placed in the human body and then to be detached.
In the embodiment of the present application, as shown in fig. 3 to 10, the valve support 1 includes a body portion 11, the body portion 11 is provided with a plurality of openings 12, the openings 12 have side walls 121, at least a portion of the openings 12 are provided with at least one first supporting portion 13, and the first supporting portion 13 is connected with the side walls 121.
In this embodiment, by arranging the first supporting portion 13 in the orifice 12 of the valve support 1, the first supporting portion 13 can improve the supporting performance of the valve support 1 along the first direction X (radial direction), and after the valve is placed in the patient, the supporting force of the valve support 1 and the diseased valve of the patient can be improved, so that the risk that the valve falls off from the diseased valve is reduced, the position accuracy of the valve is improved, the working performance of the valve is improved, and the safety of the patient is ensured.
In addition, as shown in fig. 8-10, in the working process of the valve, under the pressure of blood, the first supporting portion 13 can be deformed, for example, the first supporting portion 13 can protrude towards the outer side of the valve support 1 or can be recessed towards the inner side of the valve support 1, so that the riveting effect of the valve and the native valve annulus is improved, and the risk of valve falling is further reduced.
Specifically, as shown in fig. 3 to 7, the first supporting portion 13 separates the orifice 12 into at least one quadrilateral structure.
As described above, the valve needs to be expanded after being placed in the patient, that is, the valve needs to be deformed, so that the valve stent 1 needs to have good deformability, and since the quadrangular structure has the characteristic of being easily deformed when being stressed, when the first supporting portion 13 partitions the orifice 12 into the quadrangular structure, the valve stent 1 has high supporting force and good deformability, thereby improving the performance of the valve.
In one embodiment, as shown in fig. 3 to 7, the first supporting portion 13 at least includes a first section 131 and a second section 132 that are bent relatively, and one end of the first section 131 and one end of the second section 132 are connected along the first direction X, and the other end of the first section and the other end of the second section are respectively connected with the corresponding side wall 121.
In this embodiment, after the first and second sections 131 and 132 that are bent relatively are connected with the two side walls 121 of the orifice 12, a quadrilateral structure is enclosed, at this time, the first and second sections 131 and 132 can improve the supporting performance of the valve support 1, that is, when the valve support 1 is subjected to an external force along the first direction X, the first and second sections 131 and 132 can play a supporting role, and at the same time, when the valve support 1 is expanded, the first and second sections 131 and 132 that are bent relatively can deform at the connecting position of the two sections, thereby facilitating the expansion of the valve support 1.
The included angle between the first segment 131 and the second segment 132 may be any angle between 0 ° and 180 °, as long as the two are not located on the same straight line.
More specifically, as shown in fig. 3 to 7, the lengths of the first segment 131, the second segment 132 and the sidewall 121 are the same, so that the first segment 131, the second segment 132 and the sidewall 121 enclose a diamond or square shape.
In this embodiment, when the first segment 131, the second segment 132 and the side wall 121 enclose a diamond or square, the diamond or square structure has higher stability of deformation under the action of external force, and the diamond or square structure has the advantage of convenient processing, and improves the appearance performance of the valve support 1.
In the embodiment shown in fig. 3, after the first support portion 13 is provided, the first support portion 13 separates the orifice 12 into a quadrilateral and a hexagonal structure, both of which are deformable during expansion of the valve holder 1.
In another embodiment, as shown in fig. 6 and 7, at least two first supporting portions 13 are disposed in the orifice 12 along the second direction Y, and a predetermined distance is provided between adjacent first supporting portions 13. The preset distance may be set according to practical situations, as long as the two first supporting portions 13 do not interfere with each other in the process of pressing the valve support 1, that is, the two first supporting portions 13 have a gap along the second direction Y in the process of pressing the valve support 1, or the two first supporting portions 13 just contact with each other along the second direction Y, so as to prevent the two first supporting portions 13 from mutually pressing and affecting the expansion of the valve support 1.
In this embodiment, when at least two first supporting portions 13 are disposed in the orifice 12, the orifice 12 can be divided into at least two quadrangles, and the at least two quadrangles can further promote expansion of the valve stent 1 when the valve stent 1 is expanded.
Wherein, the two first supporting parts 13 may include a first segment 131 and a second segment 132 which are bent relatively, and the first segment 131 and the second segment 132 are connected with the side wall 121 of the orifice 12. In the embodiment shown in fig. 6 and 7, two first support portions 13 are provided in the orifice 12 in the second direction Y, so as to divide the orifice 12 into two quadrangular and one hexagonal structures.
In the above embodiments, the shape of the orifice 12 may be hexagonal. Specifically, the shape of the orifice 12 may be regular hexagonal, i.e., the length of each sidewall 121 of the orifice 12 is equal.
In this embodiment, when the hexagonal orifice 12 receives an external force, the deformation amounts of the various parts are similar, so that the valve support 1 can expand uniformly, the performance of the valve in the patient is improved, and meanwhile, the structure of the valve support 1 can be simplified, and the appearance performance of the valve is improved.
On the other hand, the material of the valve holder 1 comprises cobalt chrome alloy.
Meanwhile, the first support portion 13 is provided at the flap port 12 corresponding to the skirt 3.
One end of a skirt 3 of the traditional valve is fixedly connected with a valve leaflet 2, the other end of the skirt is fixedly connected with the bottom end of a valve bracket 1, the valve is compressed in a catheter, and when the percutaneous interventional heart valve is replaced, the skirt is expanded at a required position through balloon expansion, so that the original valve is replaced. However, the primary valve is either asynchronous in opening and closing of the valve leaflet 2, serious in reflux, serious in calcification of the valve leaflet 2 and incomplete in opening and closing, and in either case, after the percutaneous implanted valve is implanted, the stent 1 is more easily attached to the surrounding annulus and is not tight, so that blood flows into the ventricle from the gap at the edge of the valve, perivalvular leakage is caused, and when the perivalvular leakage is serious, chest distress, shortness of breath, hemolysis, anemia, angina and other complications occur after a patient is operated.
In order to solve this technical problem, as shown in fig. 1 and 2, after the skirt 3 is mounted on the valve holder 1, the area of the skirt 3 is greater than or equal to the area of the valve holder 1 so that the skirt 3 can freely move. Therefore, after the valve is placed into a human body, the skirt edge 3 can move freely, so that gaps between the valve and the peripheral annulus can be filled under the pressure of blood, the valve is tightly attached to the peripheral annulus after being placed into the human body, blood is prevented from flowing into a ventricle from the edge of the valve, the occurrence of paravalvular leakage is reduced, and finally the aim of treatment is achieved.
More specifically, as shown in fig. 1 and 2, the skirt 3 is closed along the circumference of the valve holder 1. After the percutaneous implantation of the valve, the closed skirt 3 is tightly attached to the annulus of the primary valve, so that the inflow of blood from the gap of the valve support 1 into the heart chamber of a patient can be reduced, the paravalvular leakage of the valve is reduced, the occurrence of chest distress, short breath, hemolysis, anemia, angina and other complications of the patient after the valve replacement operation is reduced, and the safety of the valve is improved.
In a specific embodiment, the skirt 3 comprises a top end and a bottom end along the height of the valve holder 1, and the top end and the bottom end are mounted to the valve holder 1, e.g. the top end and the bottom end are sewn to the valve holder 1. Meanwhile, between the top and bottom ends, the area of the skirt 3 is greater than or equal to the area of the valve holder 1, and the skirt 3 near the top end and the skirt 3 near the bottom end are connected to form a ring-shaped structure or a pleated structure.
In this embodiment, when the area of the skirt edge 3 between the top end and the bottom end is larger than the area of the valve support 1, a gap is formed between the skirt edge 3 between the top end and the bottom end and the valve support 1, so that the gap between the valve and the peripheral annulus can be filled under the pressure of blood, the valve is tightly attached to the peripheral annulus after being placed into a human body, the blood is prevented from flowing into the ventricle from the edge of the valve, and the occurrence of paravalvular leakage is reduced. At the same time, when the skirt 3 near the top end and the skirt 3 near the bottom end are joined, it is helpful to form a ring-shaped structure or a wrinkle structure on the skirt 3.
When the top end and the bottom end of the skirt 3 are sewn on the valve support 1 during valve processing, the area of the skirt 3 between the top end and the bottom end is larger than or equal to the area of the valve support 1, so that the skirt 3 can pinch an annular structure or a fold structure by itself, and then a needle thread is sewn between the top end and the bottom end from bottom to top or from top to bottom, thereby forming the annular structure or the fold structure.
In another embodiment, as shown in fig. 11, the valve holder 1 includes a plurality of first mounting openings 111, the skirt 3 is mounted on the first mounting openings 111 and seals the first mounting openings 111, and the plurality of first mounting openings 111 are located at the same height along the second direction Y, so that the skirt 3 has the annular structure shown in fig. 1.
In yet another embodiment, as shown in fig. 12, the plurality of first mounting openings 111 are located at different heights along the second direction Y, so that the skirt 3 is in a pleated structure.
In the above two embodiments, the structure enclosed by the skirt 3 is determined according to the position of each first mounting opening 111, that is, when each first mounting opening 111 is located at the same height, the skirt 3 forms an annular sewing ring, when the heights of each first mounting opening 111 are different, the skirt 3 forms an irregularly shaped sewing ring, and whichever can be tightly attached to the surrounding annulus after implantation, so that blood is prevented from flowing into the ventricle from the valve edge, the occurrence of paravalvular leakage is reduced, and finally the therapeutic purpose is achieved.
In addition, the skirt 3 is sewn to the valve holder 1 at the first mounting opening 111, so that the valve does not need to provide a support frame for the skirt 3, but the skirt 3 is sewn directly to the valve holder 1, thereby simplifying the structure of the valve.
In each of the above embodiments, as shown in fig. 1 and 2, the skirt 3 has a single-layer structure, and a part of the skirt 3 is located inside the valve holder 1 and another part protrudes outside the valve holder 1 through the first mounting opening 111.
In this embodiment, when the skirt 3 is sewn to the valve holder 1, the skirt 3 with a single layer structure may be placed in the valve holder 1, and then a part of the skirt 3 extends out of the valve holder 1 through the first mounting opening 111 and is sewn at the first mounting opening 111, so that both the inner side and the outer side of the valve holder 1 have the skirt 3, thereby further reducing the occurrence of paravalvular leakage and improving the performance of the valve. In addition, when the skirt 3 positioned on the inner side and the outer side of the valve bracket 1 is of an integrated structure, the sewing difficulty of the skirt 3 can be simplified, and the strength and the reliability of the skirt can be improved.
On the other hand, as shown in fig. 3, the valve holder 1 includes a second mounting port 112, and the second mounting port 112 is arranged in the second direction Y with the first mounting port 111, and the leaflet 2 is mounted to the second mounting port 112 and blocks the second mounting port 112. The valve support 1 has three second mounting openings 112 as shown in fig. 3, and the valve includes three valve leaflets 2, where the three second mounting openings 112 are all used for mounting the valve leaflets 2 (the valve leaflets 2 can be mounted on the second mounting openings 112 by sewing or bonding), and the included angle between the three second mounting openings 112 is 120 °, as shown in fig. 14, so that the first valve leaflets 21, the second valve leaflets 22 and the third valve leaflets 23 are symmetrically distributed, and the first valve leaflets 21, the second valve leaflets 22 and the third valve leaflets 23 are the same in size.
As shown in fig. 13, a second support portion 14 is provided at the second mounting port 112, the second support portion 14 for supporting the leaflet 2 in the first direction X.
In this embodiment, when the valve is pressed and held before being placed in the patient, the valve support 1 of the valve is deformed by the pressing and holding force, and by providing the second supporting portion 14, after the valve support 1 is deformed and contracted, the second supporting portion 14 can support the valve leaflet 2, so as to prevent the valve leaflet 2 from being crushed by the valve support 1, and improve the safety and reliability of the valve.
Wherein, as shown in fig. 13, the second support portion 14 may extend in a first direction X so as to be able to radially support the leaflet 2 during crimping of the valve.
The valve in the embodiment of the application is a balloon expansion valve.
As described above, the expansion modes of the valve include a self-expanding type and a balloon expanding type, and for the self-expanding valve, since the height of the valve stent 1 is large, when the self-expanding valve is used again for a replacement operation of "valve-in-valve" for a patient who has already adopted the self-expanding valve in the future, the newly implanted self-expanding valve has a risk of blocking the coronary artery inlet, while the valve stent 1 Gao Duyuan of the balloon expanding valve is much smaller than the height of the valve stent of the self-expanding valve, and the coronary artery inlet is not blocked at all when the replacement operation of "valve-in-valve" is performed again later. Thus, the safety of the balloon expandable valve is higher.
In addition, the valve in the embodiment of the application is a balloon expansion valve, so that when the skirt 3 is sewn on the valve bracket 1, compared with a self-expansion valve, the circumferential closing structure of the skirt 3 can be realized without a traction rope, thereby simplifying the structure of the valve.
The above is only a preferred embodiment of the present application, and is not intended to limit the present application, but various modifications and variations can be made to the present application by those skilled in the art. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application should be included in the protection scope of the present application.

Claims (9)

1.一种介入式瓣膜支架,其特征在于,所述瓣膜支架(1)包括本体部(11),所述本体部(11)设置有多个瓣口(12),所述瓣口(12)具有侧壁(121);1. An interventional valve stent, characterized in that the valve stent (1) comprises a main body (11), the main body (11) is provided with a plurality of valve openings (12), and the valve openings (12) have side walls (121); 其中,沿第二方向(Y),至少部分的所述瓣口(12)内设置有至少两个第一支撑部(13),所述第一支撑部(13)与所述侧壁(121)连接,至少两个所述第一支撑部(13)能够将所述瓣口(12)分隔为至少两个四边形;Wherein, along the second direction (Y), at least part of the valve opening (12) is provided with at least two first support portions (13), the first support portions (13) being connected to the side wall (121), and the at least two first support portions (13) being capable of dividing the valve opening (12) into at least two quadrilaterals; 所述瓣膜支架(1)包括第二安装口(112),所述第二安装口(112)处设置有第二支撑部(14),瓣膜的瓣叶(2)能够安装于所述第二安装口(112),并封堵所述第二安装口(112),所述第二支撑部(14)沿第一方向(X)延伸,所述第二支撑部(14)用于在压握瓣膜时沿径向支撑所述瓣叶(2)。The valve support (1) comprises a second mounting opening (112), wherein a second supporting portion (14) is provided at the second mounting opening (112), wherein the leaflets (2) of the valve can be mounted on the second mounting opening (112) and seal the second mounting opening (112), wherein the second supporting portion (14) extends along a first direction (X), and is used to support the leaflets (2) in a radial direction when the valve is pressed and gripped. 2.根据权利要求1所述的介入式瓣膜支架,其特征在于,所述第一支撑部(13)至少包括相对弯折的第一段(131)和第二段(132);2. The invasive valve stent according to claim 1, characterized in that the first support portion (13) comprises at least a first section (131) and a second section (132) that are bent relative to each other; 沿第一方向(X),所述第一段(131)与所述第二段(132)的一端连接,二者的另一端分别与对应的所述侧壁(121)连接。Along a first direction (X), one end of the first section (131) is connected to the second section (132), and the other ends of the two are respectively connected to the corresponding side wall (121). 3.根据权利要求2所述的介入式瓣膜支架,其特征在于,所述第一段(131)、所述第二段(132)和所述侧壁(121)长度相同,以使所述第一段(131)、所述第二段(132)和所述侧壁(121)围成菱形或正方形。3. The interventional valve stent according to claim 2, characterized in that the first section (131), the second section (132) and the side wall (121) are of the same length so that the first section (131), the second section (132) and the side wall (121) form a rhombus or a square. 4.根据权利要求2所述的介入式瓣膜支架,其特征在于,相邻所述第一支撑部(13)之间具有预设距离。4. The interventional valve stent according to claim 2, characterized in that there is a preset distance between adjacent first supporting portions (13). 5.根据权利要求1~4中任一项所述的介入式瓣膜支架,其特征在于,至少部分所述第一支撑部(13)能够朝向所述瓣口(12)的外侧外凸,或者,至少部分所述第一支撑部(13)能够朝向所述瓣口(12)的外侧内凹。5. The interventional valve stent according to any one of claims 1 to 4, characterized in that at least a portion of the first support portion (13) can bulge outward toward the outside of the valve orifice (12), or at least a portion of the first support portion (13) can be concave toward the outside of the valve orifice (12). 6.根据权利要求1~4中任一项所述的介入式瓣膜支架,其特征在于,所述瓣口(12)的形状为六边形。6. The invasive valve stent according to any one of claims 1 to 4, characterized in that the shape of the valve opening (12) is hexagonal. 7.根据权利要求1~4中任一项所述的介入式瓣膜支架,其特征在于,所述瓣膜支架(1)的材料包括钴基合金、不锈钢或镍钛。7. The invasive valve stent according to any one of claims 1 to 4, characterized in that the material of the valve stent (1) comprises cobalt-based alloy, stainless steel or nickel titanium. 8.一种瓣膜,其特征在于,所述瓣膜包括:8. A valve, characterized in that the valve comprises: 瓣膜支架(1),所述瓣膜支架(1)为权利要求1~7中任一项所述的介入式瓣膜支架(1);A valve stent (1), wherein the valve stent (1) is the interventional valve stent (1) according to any one of claims 1 to 7; 瓣叶(2),所述瓣叶(2)安装于所述瓣膜支架(1)。A valve leaflet (2), wherein the valve leaflet (2) is mounted on the valve support (1). 9.根据权利要求8所述的瓣膜,其特征在于,所述瓣膜为球囊扩张式瓣膜。9. The valve according to claim 8 is characterized in that the valve is a balloon-expandable valve.
CN202110842126.3A 2021-07-26 2021-07-26 An interventional valve stent and valve Active CN113558825B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110842126.3A CN113558825B (en) 2021-07-26 2021-07-26 An interventional valve stent and valve

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110842126.3A CN113558825B (en) 2021-07-26 2021-07-26 An interventional valve stent and valve

Publications (2)

Publication Number Publication Date
CN113558825A CN113558825A (en) 2021-10-29
CN113558825B true CN113558825B (en) 2025-04-15

Family

ID=78167149

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110842126.3A Active CN113558825B (en) 2021-07-26 2021-07-26 An interventional valve stent and valve

Country Status (1)

Country Link
CN (1) CN113558825B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025117348A1 (en) * 2023-11-28 2025-06-05 St. Jude Medical, Cardiology Division, Inc. Pleated cuff for prosthetic heart valve

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN202568532U (en) * 2008-06-06 2012-12-05 爱德华兹生命科学公司 Implantable artificial valve
CN210541937U (en) * 2019-04-08 2020-05-19 北京佰仁医疗科技股份有限公司 Connection structure of stent and valve leaflet and interventional valve-in-valve and interventional aortic valve using the connection structure
CN211633744U (en) * 2019-11-12 2020-10-09 上海纽脉医疗科技有限公司 Transcatheter intervention type artificial valve
CN215739675U (en) * 2021-07-26 2022-02-08 杭州心畅医疗器械有限公司 Novel intervention type valve support and valve

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113133852A (en) * 2020-01-17 2021-07-20 徐冠彪 Prosthetic valve and method of making same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN202568532U (en) * 2008-06-06 2012-12-05 爱德华兹生命科学公司 Implantable artificial valve
CN210541937U (en) * 2019-04-08 2020-05-19 北京佰仁医疗科技股份有限公司 Connection structure of stent and valve leaflet and interventional valve-in-valve and interventional aortic valve using the connection structure
CN211633744U (en) * 2019-11-12 2020-10-09 上海纽脉医疗科技有限公司 Transcatheter intervention type artificial valve
CN215739675U (en) * 2021-07-26 2022-02-08 杭州心畅医疗器械有限公司 Novel intervention type valve support and valve

Also Published As

Publication number Publication date
CN113558825A (en) 2021-10-29

Similar Documents

Publication Publication Date Title
JP5687070B2 (en) Stent for prosthetic heart valve
JP5685183B2 (en) Heart valve device with stent
CN109561961B (en) A kind of artificial valve and artificial valve implantation method
KR102582303B1 (en) aortic replacement valve
US10925724B2 (en) Replacement valve and anchor
EP3361988B1 (en) Mitral valve assembly
JP5812446B2 (en) Stent for prosthetic heart valve
JP6050534B2 (en) Prosthetic heart valve
CN103228232B (en) There is the prosthetic heart valve framework of flexible Colaesce
JP2022132283A (en) System with prosthetic heart valve
CN216535661U (en) Implantable prosthetic device
JP6513699B2 (en) Inverted leaflet artificial valve
US8709077B2 (en) Methods of implanting minimally-invasive prosthetic heart valves
EP2918248A1 (en) An expandable stent-valve and a delivery device
WO2018184225A1 (en) Artificial heart valve
CN110711052A (en) Transcatheter intervention type artificial valve
CN113558825B (en) An interventional valve stent and valve
CN111053629B (en) Heart valve support and prosthesis thereof
CN215739675U (en) Novel intervention type valve support and valve
CN216021548U (en) Valve
CN113331999B (en) Valve prosthesis
CN113558824B (en) Valve
CN216221867U (en) Valve support and artificial valve device comprising same
CN212466057U (en) Self-expanding plugging device
CN114191146A (en) Valve support and artificial valve device comprising same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Wang Jianan

Inventor after: Liu Xianbao

Inventor after: Fu Zhibin

Inventor after: Yu Dawei

Inventor before: Fu Zhibin

Inventor before: Yu Dawei

Inventor before: Hou Wenbo

Inventor before: Wang Jianan

Inventor before: Liu Xianbao

GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20250813

Address after: 311121 Zhejiang Province, Hangzhou City, Yuhang District, Yuhang Street, Jinxing Village, Plot 9-116-18-17, Building No. 1, First Floor, Room 110

Patentee after: Hangzhou Xinchang Medical Instrument Co.,Ltd.

Country or region after: China

Patentee after: ZHEJIANG University

Address before: 311121 Zhejiang Province, Hangzhou City, Yuhang District, Yuhang Street, Jinxing Village, Plot 9-116-18-17, Building No. 1, First Floor, Room 110

Patentee before: Hangzhou Xinchang Medical Instrument Co.,Ltd.

Country or region before: China